Adlai Nortye Stock Forum

$Adlai Nortye (ANL.US)$
AN4005
·     In an ongoing Phase 1 study (NCT04999384), the Company is investigating the safety of AN4005, its oral small-molecule PD-L1 inhibitor.
·     The Company plans to provide a clinical update in the second half of 2024.
·     The expansion cohort portion of the trial for IO treatment-naïve patients was initiated in July 2024.

$Adlai Nortye (ANL.US)$ not good for now

$Adlai Nortye (ANL.US)$
lol ... expensive IPO ... immediate drop

$Adlai Nortye (ANL.US)$ why is it saying no trading in this stock when I try to buy?

$Adlai Nortye (ANL.US)$ 👀

$Adlai Nortye (ANL.US)$
LFG already! Bigger is better as far as IPOs in 2023 - see $VinFast Auto (VFS.US)$